Volunteer for a Clinical Trial

Looking to take part in a clinical trial?

Volunteer satisfaction is our primary focus.

Uncompromising attention to delivering quality clinical research and ensuring the safety of our volunteers.

Quotient Sciences is dedicated to early drug development, with experience that spans more than 30 years and more than 1,300 Phase I studies delivered at our clinical units in Miami and Nottingham.

Through clinical trials, we've worked with our volunteers and pharmaceutical partners to develop new treatments for a range of conditions, including cancer, pediatric rare diseases, infectious disease, and heart disease.

Clinical Pharmacology Fact Sheet
Join us for our next webinar
 

More than three decades of experience in clinical trials

Join us for our next webinar
 

Over 1,300 clinical trials completed

Join us for our next webinar
 

Programs with leading, global pharmaceutical and biotech companies

Join us for our next webinar
 

A dedicated recruitment team that supports trial participants before, during, and after their stay 

Our global clinical trials locations

Participate in UK clinical trials at our clinic

Nottingham, UK

Image
nottingham clinical trials

Visit our Nottingham clinic:

Quotient Sciences - Nottingham
Mere Way
Ruddington Fields
Ruddington, Nottingham
NG11 6JS


Call our Nottingham clinic:

0330 303 5000


Visit our website for information on current Nottingham clinical trials:

weneedyoutrials.com

Participate in US clinical trials at our clinic

Miami, FL

Image
miami outside of building

Visit our Miami clinic:

Quotient Sciences - Miami
747 Ponce De Leon Blvd Suite 700
Coral Gables, FL 33134


Call our Miami clinic:

305-646-6785


Visit our website for information on current Miami clinical trials:

English: weneedyoutrials.com/us

Español: weneedyoutrials.com/es

Clinical Pharmacology Services
Clinical Pharmacology

Clinical Pharmacology Info Sheet

10 March 2025 Read More
For Sponsors
Learn about our clinical pharmacology services & capabilities for first-in-human Phase I trials